This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Progressive multifocal leucoencephalopathy

Authoring team

Progressive multifocal leucoencephalopathy (PML) is a multifocal demyelinating disease of the brain's white matter.

PML is caused by reactivation of latent JC papova virus. It occurs in association with systemic illness in which cell-mediated and often, humoral immunity is depressed:

  • AIDS
  • immunosuppressive therapy
  • sarcoidosis
  • systemic lupus erythematosus
  • lymphoma

Features include personality change, dementia, hemiparesis, cortical visual loss, and seizures.

Papova virus is evident in oligodendroglia on electron microscopy. CT and MRI reveal widespread multifocal damage to the white matter. Definitive diagnosis is made by brain biopsy. The virus can be isolated by inoculation on to glial tissue culture.

Antiviral agents have been unsuccessful. Death usually occurs within 3-6 months.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.